Regeneron reports positive interim data with REGEN-COV(TM) antibody cocktail used as passive vaccine to prevent COVID-19

Dear Investor, Please find attached a press release from our partner Regeneron:https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-positive-interim-data-regen-covtm-antibodyDo not hesitate to contact us for any further questions. With best regards,
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news